Clinical TrialsSearch results
Number of results: 446
Other
- Discontinuation of infliximab therapy after acquisition of low disease activity by infliximab in rheumatoid arthritis study: RRR (remission induction by remicade) study
- rheumatoid arthritis
- University of Occupational & Environmental Health, Japan
- 2009-06-23
Recruiting
- Efficacy and safety study ofglycyrrhetinic acid / CMC-Na ointment for oral lichen planus
- Oral lichen planus
- Uchida Fumihiko
- 2022-08-31
Other
- Clinical reseach of video assisted neck surgery for papillary thyroid carcinoma
- papillary thyroid carcinoma
- Tsukuba University Hospital
- 2008-04-01
Other
- Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer
- colorectal cancer
- Tsukuba Cancer Clinical Trial Group
- 2008-12-03
Other
- Multicenter phase II study of S-1 plus Weekly Cisplatin in first-line treatment of unresectable or reccurent gastric cancer
- gastric cancer
- Tsukuba Cancer Clinical Trial Group
- 2009-04-07
Completed
- Exploratory Clinical Trial to Evaluate the Efficacy and Safety of a Centella Asiatica Supplement for Ulcerative Colitis
- Ulcerative Colitis
- Tsuchiya Kiichiro
- 2022-08-31
Other
- BEDTIME ADMINISTRATION OF LONG-ACTING ANTIHYPERTENSIVE DRUGS RESTORES NORMAL NOCTURNAL BLOOD PRESSURE FALL IN NON-DIPPERS WITH ESSENTIAL HYPERTENSION
- Essential hypertension
- Tsuchiura Kyodo General Hospital
- 2007-07-13
Other
- Long-term evolution and changing associations of left ventricular hypertrophy after starting hemodialysis
- hemodialysis
- Tsuchiura Kyodo General Hospital
- 2007-06-20
Recruiting
- Exploratory study for the usefulness of early introduction of anifrolumab in the first remission induction therapy for systemic lupus erythematosus
- systemic lupus erythematosus
- Tsuboi Hiroto
- 2023-09-22
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30